{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:39:25Z","timestamp":1759667965840},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00784-016-1911-3","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T20:56:17Z","timestamp":1469134577000},"page":"1503-1508","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer"],"prefix":"10.1007","volume":"21","author":[{"given":"Julie C.","family":"Nienstedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gr\u00f6be","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lebok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"B\u00fcscheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmus","family":"Heumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Moebius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"M\u00fcnscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainald","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Blessmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Pflug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"issue":"2","key":"1911_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2002","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55(2):74\u20131082005","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1911_CR2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.20740","volume":"114","author":"AL Carvalho","year":"2005","unstructured":"Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114(5):806\u2013816","journal-title":"Int J Cancer"},{"issue":"1","key":"1911_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1911_CR4","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.161.6.3087","volume":"161","author":"H Hasegawa","year":"1998","unstructured":"Hasegawa H, Nomura T, Kishimoto K, Yanagisawa K (1998) Fujita S. SFA-1\/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with alpha 5 beta 1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin. J Immunol 161(6):3087\u20133095","journal-title":"J Immunol"},{"issue":"Pt 1","key":"1911_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj3380061","volume":"338","author":"S Fitter","year":"1999","unstructured":"Fitter S, Sincock PM, Jolliffe CN, Ashman LK (1999) Transmembrane 4 superfamily protein CD151 (PETA-3) associates with beta 1 and alpha IIb beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J 338(Pt 1):61\u201370","journal-title":"Biochem J"},{"issue":"4","key":"1911_CR6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1083\/jcb.149.4.969","volume":"149","author":"LM Sterk","year":"2000","unstructured":"Sterk LM, Geuijen CA, Oomen LC, Calafat J, Janssen H, Sonnenberg A (2000) The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J Cell Biol 149(4):969\u2013982","journal-title":"J Cell Biol"},{"issue":"3","key":"1911_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1083\/jcb.141.3.791","volume":"141","author":"M Yanez-Mo","year":"1998","unstructured":"Yanez-Mo M, Alfranca A, Cabanas C, Marazuela M, Tejedor R, Ursa MA, et al. (1998) Regulation of endothelial cell motility by complexes of tetraspan molecules CD81\/TAPA-1 and CD151\/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol 141(3):791\u2013804","journal-title":"J Cell Biol"},{"issue":"4","key":"1911_CR8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2006-08-041970","volume":"109","author":"Y Takeda","year":"2007","unstructured":"Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, Kaipainen A, et al. (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109(4):1524\u20131532","journal-title":"Blood"},{"issue":"4","key":"1911_CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/002215549704500404","volume":"45","author":"PM Sincock","year":"1997","unstructured":"Sincock PM, Mayrhofer G, Ashman LK (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 45(4):515\u2013525","journal-title":"J Histochem Cytochem"},{"issue":"8","key":"1911_CR10","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood-2004-04-1512","volume":"104","author":"V Karamatic Crew","year":"2004","unstructured":"Karamatic Crew V, Burton N, Kagan A, Green CA, Levene C, Flinter F, et al. (2004) CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104(8):2217\u20132223","journal-title":"Blood"},{"issue":"11 Pt 1","key":"1911_CR11","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1055-9965.1717.13.11","volume":"13","author":"J Ang","year":"2004","unstructured":"Ang J, Lijovic M, Ashman LK, Kan K, Frauman AG (2004) CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomark Prev 13(11 Pt 1):1717\u20131721","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"12","key":"1911_CR12","first-page":"4109","volume":"7","author":"T Tokuhara","year":"2001","unstructured":"Tokuhara T, Hasegawa H, Hattori N, Ishida H, Taki T, Tachibana S, et al. (2001) Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res 7(12):4109\u20134114","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1911_CR13","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/0008-5472.CAN-07-2949","volume":"68","author":"XH Yang","year":"2008","unstructured":"Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, et al. (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68(9):3204\u20133213","journal-title":"Cancer Res"},{"issue":"8","key":"1911_CR14","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/1078-0432.CCR-04-1935","volume":"11","author":"S Gesierich","year":"2005","unstructured":"Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, Schmitz-Winnenthal FH, et al. (2005) Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 11(8):2840\u20132852","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1911_CR15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.22639","volume":"49","author":"AW Ke","year":"2009","unstructured":"Ke AW, Shi GM, Zhou J, FZ W, Ding ZB, MY H, et al. (2009) Role of overexpression of CD151 and\/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49(2):491\u2013503","journal-title":"Hepatology"},{"issue":"1","key":"1911_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hep.23661","volume":"52","author":"GM Shi","year":"2010","unstructured":"Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, Ding ZB, et al. (2010) CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 52(1):183\u2013196","journal-title":"Hepatology"},{"issue":"3","key":"1911_CR17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1245\/s10434-010-1387-3","volume":"18","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Miyazaki T, Tanaka N, Sakai M, Sano A, Inose T, et al. (2011) Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness. Ann Surg Oncol 18(3):888\u2013893","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1911_CR18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.bjc.6601015","volume":"89","author":"H Hashida","year":"2003","unstructured":"Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, et al. (2003) Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer 89(1):158\u2013167","journal-title":"Br J Cancer"},{"issue":"14","key":"1911_CR19","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/onc.2012.205","volume":"32","author":"Q Li","year":"2013","unstructured":"Li Q, Yang XH, Xu F, Sharma C, Wang HX, Knoblich K, et al. (2013) Tetraspanin CD151 plays a key role in skin squamous cell carcinoma. Oncogene 32(14):1772\u20131783","journal-title":"Oncogene"},{"issue":"5","key":"1911_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PAT.0b013e32835576ee","volume":"44","author":"S Minner","year":"2012","unstructured":"Minner S, De Silva C, Rink M, Dahlem R, Chun F, Fisch M, et al. (2012) Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer. Pathology 44(5):448\u2013452","journal-title":"Pathology"},{"issue":"24","key":"1911_CR21","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1158\/1078-0432.CCR-08-1651","volume":"14","author":"CW Chien","year":"2008","unstructured":"Chien CW, Lin SC, Lai YY, Lin BW, Lin SC, Lee JC, et al. (2008) Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin Cancer Res 14(24):8043\u20138051","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1911_CR22","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ijc.24297","volume":"124","author":"C Hirano","year":"2009","unstructured":"Hirano C, Nagata M, Noman AA, Kitamura N, Ohnishi M, Ohyama T, et al. (2009) Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma. Int J Cancer 124(12):2911\u20132916","journal-title":"Int J Cancer"},{"issue":"3","key":"1911_CR23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.oraloncology.2012.09.013","volume":"49","author":"HM Romanska","year":"2013","unstructured":"Romanska HM, Potemski P, Collins SI, Williams H, Parmar S, Berditchevski F (2013) Loss of CD151\/Tspan24 from the complex with integrin alpha3beta1 in invasive front of the tumour is a negative predictor of disease-free survival in oral squamous cell carcinoma. Oral Oncol 49(3):224\u2013229","journal-title":"Oral Oncol"},{"issue":"7","key":"1911_CR24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844\u2013847","journal-title":"Nat Med"},{"issue":"3","key":"1911_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jop.12111","volume":"43","author":"A Gr\u00f6be","year":"2014","unstructured":"Gr\u00f6be A, Eichhorn W, Fraederich M, Kluwe L, Vashist Y, Wikner J, et al. (2014) Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. J Oral Pathol Med 43(3):205\u2013210","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"1911_CR26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00784-013-0939-x","volume":"18","author":"A Gr\u00f6be","year":"2014","unstructured":"Gr\u00f6be A, Hanken H, Al-Dam A, Cachovan G, Smeets R, Krohn A, et al. (2014) P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region. Clin Oral Investig 18(1):211\u2013217","journal-title":"Clin Oral Investig"},{"issue":"9","key":"1911_CR27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/jop.12086","volume":"42","author":"A Gr\u00f6be","year":"2013","unstructured":"Gr\u00f6be A, Hanken H, Kluwe L, Schollchen M, Tribius S, Pohlenz P, et al. (2013) Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma. J Oral Pathol Med 42(9):676\u2013681","journal-title":"J Oral Pathol Med"},{"issue":"11","key":"1911_CR28","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1038\/bjc.2013.600","volume":"109","author":"P Nankivell","year":"2013","unstructured":"Nankivell P, Williams H, McConkey C, Webster K, High A, MacLennan K, et al. (2013) Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. Br J Cancer 109(11):2864\u20132874","journal-title":"Br J Cancer"},{"issue":"6","key":"1911_CR29","first-page":"1179","volume":"63","author":"K Freier","year":"2003","unstructured":"Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, et al. (2003) Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63(6):1179\u20131182","journal-title":"Cancer Res"},{"issue":"6D","key":"1911_CR30","first-page":"5213","volume":"23","author":"R Ishiguro","year":"2003","unstructured":"Ishiguro R, Fujii M, Yamashita T, Tashiro M, Tomita T, Ogawa K, et al. (2003) CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma. Anticancer Res 23(6D):5213\u20135220","journal-title":"Anticancer Res"},{"issue":"1","key":"1911_CR31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00784-013-0967-6","volume":"18","author":"H Hanken","year":"2014","unstructured":"Hanken H, Gr\u00f6be A, Cachovan G, Smeets R, Simon R, Sauter G, et al. (2014) CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Clin Oral Investig 18(1):269\u2013276","journal-title":"Clin Oral Investig"},{"issue":"5\u00a0A","key":"1911_CR32","first-page":"3971","volume":"23","author":"K Freier","year":"2003","unstructured":"Freier K, Bosch FX, Flechtenmacher C, Devens F, Benner A, Lichter P, et al. (2003) Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysis. Anticancer Res 23(5\u00a0A):3971\u20133977","journal-title":"Anticancer Res"},{"issue":"7","key":"1911_CR33","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00005537-200107000-00029","volume":"111","author":"JP Rodrigo","year":"2001","unstructured":"Rodrigo JP, Su\u00e1rez C, Gonz\u00e1lez MV, Lazo PS, Ramos S, Coto E, et al. (2001) Variability of genetic alterations in different sites of head and neck cancer. Laryngoscope 111(7):1297\u20131301","journal-title":"Laryngoscope"},{"issue":"15","key":"1911_CR34","first-page":"3812","volume":"59","author":"JE Testa","year":"1999","unstructured":"Testa JE, Brooks PC, Lin JM, Quigley JP (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3\/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59(15):3812\u20133820","journal-title":"Cancer Res"},{"issue":"3","key":"1911_CR35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.1605","volume":"97","author":"M Kohno","year":"2002","unstructured":"Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S (2002) CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97(3):336\u2013343","journal-title":"Int J Cancer"},{"issue":"3","key":"1911_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccr.2008.01.031","volume":"13","author":"A Zijlstra","year":"2008","unstructured":"Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP (2008) The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13(3):221\u2013234","journal-title":"Cancer Cell"},{"issue":"5","key":"1911_CR37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2009.192","volume":"23","author":"M Woegerbauer","year":"2010","unstructured":"Woegerbauer M, Thurnher D, Houben R, Pammer J, Kloimstein P, Heiduschka G, et al. (2010) Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression. Mod Pathol 23(5):751\u2013762","journal-title":"Mod Pathol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-1911-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1911-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T11:08:46Z","timestamp":1718708926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-1911-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-1911-3","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}